Your browser doesn't support javascript.
loading
Safe engineering of cancer-associated fibroblasts enhances checkpoint blockade immunotherapy.
Geng, Shizhen; Xiang, Tingting; Zhang, Yunya; Guo, Pengke; Zhang, Hongling; Zhang, Zhenzhong; Gu, Mengchao; Zhang, Kaixiang; Song, Haiwei; Shi, Jinjin; Liu, Junjie.
Afiliación
  • Geng S; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Xiang T; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Zhang Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Guo P; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Zhang H; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, China; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou 450001, China.
  • Zhang Z; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, China; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou 450001, China; State Key Labora
  • Gu M; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Zhang K; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, China; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou 450001, China.
  • Song H; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), Singapore 138673, Singapore. Electronic address: haiwei@imcb.a-star.edu.sg.
  • Shi J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, China; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou 450001, China. Electronic addre
  • Liu J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, China; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou 450001, China. Electronic addre
J Control Release ; 356: 272-287, 2023 04.
Article en En | MEDLINE | ID: mdl-36870541
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Fibroblastos Asociados al Cáncer / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Female / Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Fibroblastos Asociados al Cáncer / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Female / Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China